Assignment : Mild Vascular Neurocognitive Disorder

Explain the diagnostic criteria for this disorder
Explain the evidenced-based psychotherapy and  psychopharmacologic treatment for Mild vascular neurocognitive disorder.
Identify the risks of different types of therapy and explain how the benefits of the therapy that might be achieved might  outweigh the risks.
Support your rationale with references to the Learning      Resources or other academic resource.

 Required Readings( Need 3 + references).
Acadia Pharmaceuticals. (2017). Transform the treatment of Parkinsons disease psychosis with NUPLAZID. Retrieved from https://www.nuplazidhcp.com/?gclid=CIHS5auvwtMCFQkaaQodrU0FGQ
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
· Neurocognitive Disorders
Gabbard, G. O. (2014). Gabbards treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.
· Chapter 63, Delirium
· Chapter 64, Neurocognitive Disorder Due to Alzheimers Disease
· Chapter 65, Frontotemporal Neurocognitive Disorder
· Chapter 66, Vascular Neurocognitive Disorder
· Chapter 67, Neurocognitive Disorder Due to Parkinsons Disease
Hopkins, S. A., & Chan, D. (2016). Key emerging issues in frontotemporal dementia. Journal of Neurology, 263(2), 407“413. doi:10.1007/s00415-015-7880-7
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadocks synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.
· Chapter 21, Neurocognitive Disorders (pp. 694“741)
Stahl, S. M. (2017). Prescribers Guide: Stahls Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press.